Outcomes of intrathecal baclofen (ITB) therapy in spacticity

Spasticity is associated with various neurological conditions. Intrathecal baclofen (ITB) is one of the popular treatments for severe spasticity. In this paper we present our experience in treating 30 patients with both spinal and supraspinal spasticity with chronic infusion of Baclofen to evaluate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Turkish neurosurgery 2011-01, Vol.21 (1), p.59-65
Hauptverfasser: Ucar, Tanju, Kazan, Saim, Turgut, Umut, Samanci, Nehir Karaman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 59
container_title Turkish neurosurgery
container_volume 21
creator Ucar, Tanju
Kazan, Saim
Turgut, Umut
Samanci, Nehir Karaman
description Spasticity is associated with various neurological conditions. Intrathecal baclofen (ITB) is one of the popular treatments for severe spasticity. In this paper we present our experience in treating 30 patients with both spinal and supraspinal spasticity with chronic infusion of Baclofen to evaluate the long term efficacy of this treatment on spasticity, disability and pain, and to evaluate the side effects of intrathecal Baclofen. The medical records of 30 patients who underwent baclofen pump placement from 2000 to 2010 under Department of Neurosurgery at the University of Akdeniz at Antalya/Turkey, were reviewed. All study subjects had diffuse chronic, severe, and generalized spasticity (Ashworth score ≥ 3), and had shown inadequate response to various oral antispastic drugs including baclofen. All patients were evaluated by means of the Ashworth score, spasm frequency, Barthel index, Rankin scales and VAS. Spasticity and spasm frequency and pain scores were clinically and statistically decreased in all patients. ITB therapy increases the quality of lifestyle and functional independence by reducing not only cerebral but also spinal related spasticity in appropriately selected cases.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_849431239</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>849431239</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-7cd8b29af25affd2f1836aacaf792360934ec01e77cf96cc205e5533c38cae793</originalsourceid><addsrcrecordid>eNo1j0tLw0AUhWeh2Fr9CzI7dRGYVx4DbrRYLRS6qetwc3MHI3k5M1nk3xuxrg4cPj7OuWBrKaRNUmnsil2H8CVElikpr9hKSWWNsHrNno5TxKGjwAfHmz56iJ-E0PIKsB0c9fxhf3p55EvrYZwXhIcRMDbYxPmGXTpoA92ec8M-dq-n7XtyOL7tt8-HZJRGxCTHuqiUBadScK5WThY6A0BwuVU6W3YYQiEpz9HZDFGJlNJUa9QFAuVWb9j9n3f0w_dEIZZdE5DaFnoaplAWxhotlf4l787kVHVUl6NvOvBz-X9Y_wA4N1BI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>849431239</pqid></control><display><type>article</type><title>Outcomes of intrathecal baclofen (ITB) therapy in spacticity</title><source>MEDLINE</source><source>EZB Free E-Journals</source><creator>Ucar, Tanju ; Kazan, Saim ; Turgut, Umut ; Samanci, Nehir Karaman</creator><creatorcontrib>Ucar, Tanju ; Kazan, Saim ; Turgut, Umut ; Samanci, Nehir Karaman</creatorcontrib><description>Spasticity is associated with various neurological conditions. Intrathecal baclofen (ITB) is one of the popular treatments for severe spasticity. In this paper we present our experience in treating 30 patients with both spinal and supraspinal spasticity with chronic infusion of Baclofen to evaluate the long term efficacy of this treatment on spasticity, disability and pain, and to evaluate the side effects of intrathecal Baclofen. The medical records of 30 patients who underwent baclofen pump placement from 2000 to 2010 under Department of Neurosurgery at the University of Akdeniz at Antalya/Turkey, were reviewed. All study subjects had diffuse chronic, severe, and generalized spasticity (Ashworth score ≥ 3), and had shown inadequate response to various oral antispastic drugs including baclofen. All patients were evaluated by means of the Ashworth score, spasm frequency, Barthel index, Rankin scales and VAS. Spasticity and spasm frequency and pain scores were clinically and statistically decreased in all patients. ITB therapy increases the quality of lifestyle and functional independence by reducing not only cerebral but also spinal related spasticity in appropriately selected cases.</description><identifier>ISSN: 1019-5149</identifier><identifier>PMID: 21294093</identifier><language>eng</language><publisher>Turkey</publisher><subject>Adolescent ; Adult ; Baclofen - administration &amp; dosage ; Baclofen - adverse effects ; Child ; Child, Preschool ; Disability Evaluation ; Female ; Follow-Up Studies ; Humans ; Infusion Pumps, Implantable ; Injections, Spinal ; Male ; Middle Aged ; Muscle Relaxants, Central - administration &amp; dosage ; Muscle Relaxants, Central - adverse effects ; Muscle Spasticity - drug therapy ; Pain - drug therapy ; Treatment Outcome ; Young Adult</subject><ispartof>Turkish neurosurgery, 2011-01, Vol.21 (1), p.59-65</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21294093$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ucar, Tanju</creatorcontrib><creatorcontrib>Kazan, Saim</creatorcontrib><creatorcontrib>Turgut, Umut</creatorcontrib><creatorcontrib>Samanci, Nehir Karaman</creatorcontrib><title>Outcomes of intrathecal baclofen (ITB) therapy in spacticity</title><title>Turkish neurosurgery</title><addtitle>Turk Neurosurg</addtitle><description>Spasticity is associated with various neurological conditions. Intrathecal baclofen (ITB) is one of the popular treatments for severe spasticity. In this paper we present our experience in treating 30 patients with both spinal and supraspinal spasticity with chronic infusion of Baclofen to evaluate the long term efficacy of this treatment on spasticity, disability and pain, and to evaluate the side effects of intrathecal Baclofen. The medical records of 30 patients who underwent baclofen pump placement from 2000 to 2010 under Department of Neurosurgery at the University of Akdeniz at Antalya/Turkey, were reviewed. All study subjects had diffuse chronic, severe, and generalized spasticity (Ashworth score ≥ 3), and had shown inadequate response to various oral antispastic drugs including baclofen. All patients were evaluated by means of the Ashworth score, spasm frequency, Barthel index, Rankin scales and VAS. Spasticity and spasm frequency and pain scores were clinically and statistically decreased in all patients. ITB therapy increases the quality of lifestyle and functional independence by reducing not only cerebral but also spinal related spasticity in appropriately selected cases.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Baclofen - administration &amp; dosage</subject><subject>Baclofen - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Infusion Pumps, Implantable</subject><subject>Injections, Spinal</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle Relaxants, Central - administration &amp; dosage</subject><subject>Muscle Relaxants, Central - adverse effects</subject><subject>Muscle Spasticity - drug therapy</subject><subject>Pain - drug therapy</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>1019-5149</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLw0AUhWeh2Fr9CzI7dRGYVx4DbrRYLRS6qetwc3MHI3k5M1nk3xuxrg4cPj7OuWBrKaRNUmnsil2H8CVElikpr9hKSWWNsHrNno5TxKGjwAfHmz56iJ-E0PIKsB0c9fxhf3p55EvrYZwXhIcRMDbYxPmGXTpoA92ec8M-dq-n7XtyOL7tt8-HZJRGxCTHuqiUBadScK5WThY6A0BwuVU6W3YYQiEpz9HZDFGJlNJUa9QFAuVWb9j9n3f0w_dEIZZdE5DaFnoaplAWxhotlf4l787kVHVUl6NvOvBz-X9Y_wA4N1BI</recordid><startdate>201101</startdate><enddate>201101</enddate><creator>Ucar, Tanju</creator><creator>Kazan, Saim</creator><creator>Turgut, Umut</creator><creator>Samanci, Nehir Karaman</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201101</creationdate><title>Outcomes of intrathecal baclofen (ITB) therapy in spacticity</title><author>Ucar, Tanju ; Kazan, Saim ; Turgut, Umut ; Samanci, Nehir Karaman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-7cd8b29af25affd2f1836aacaf792360934ec01e77cf96cc205e5533c38cae793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Baclofen - administration &amp; dosage</topic><topic>Baclofen - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Infusion Pumps, Implantable</topic><topic>Injections, Spinal</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle Relaxants, Central - administration &amp; dosage</topic><topic>Muscle Relaxants, Central - adverse effects</topic><topic>Muscle Spasticity - drug therapy</topic><topic>Pain - drug therapy</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ucar, Tanju</creatorcontrib><creatorcontrib>Kazan, Saim</creatorcontrib><creatorcontrib>Turgut, Umut</creatorcontrib><creatorcontrib>Samanci, Nehir Karaman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Turkish neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ucar, Tanju</au><au>Kazan, Saim</au><au>Turgut, Umut</au><au>Samanci, Nehir Karaman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of intrathecal baclofen (ITB) therapy in spacticity</atitle><jtitle>Turkish neurosurgery</jtitle><addtitle>Turk Neurosurg</addtitle><date>2011-01</date><risdate>2011</risdate><volume>21</volume><issue>1</issue><spage>59</spage><epage>65</epage><pages>59-65</pages><issn>1019-5149</issn><abstract>Spasticity is associated with various neurological conditions. Intrathecal baclofen (ITB) is one of the popular treatments for severe spasticity. In this paper we present our experience in treating 30 patients with both spinal and supraspinal spasticity with chronic infusion of Baclofen to evaluate the long term efficacy of this treatment on spasticity, disability and pain, and to evaluate the side effects of intrathecal Baclofen. The medical records of 30 patients who underwent baclofen pump placement from 2000 to 2010 under Department of Neurosurgery at the University of Akdeniz at Antalya/Turkey, were reviewed. All study subjects had diffuse chronic, severe, and generalized spasticity (Ashworth score ≥ 3), and had shown inadequate response to various oral antispastic drugs including baclofen. All patients were evaluated by means of the Ashworth score, spasm frequency, Barthel index, Rankin scales and VAS. Spasticity and spasm frequency and pain scores were clinically and statistically decreased in all patients. ITB therapy increases the quality of lifestyle and functional independence by reducing not only cerebral but also spinal related spasticity in appropriately selected cases.</abstract><cop>Turkey</cop><pmid>21294093</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1019-5149
ispartof Turkish neurosurgery, 2011-01, Vol.21 (1), p.59-65
issn 1019-5149
language eng
recordid cdi_proquest_miscellaneous_849431239
source MEDLINE; EZB Free E-Journals
subjects Adolescent
Adult
Baclofen - administration & dosage
Baclofen - adverse effects
Child
Child, Preschool
Disability Evaluation
Female
Follow-Up Studies
Humans
Infusion Pumps, Implantable
Injections, Spinal
Male
Middle Aged
Muscle Relaxants, Central - administration & dosage
Muscle Relaxants, Central - adverse effects
Muscle Spasticity - drug therapy
Pain - drug therapy
Treatment Outcome
Young Adult
title Outcomes of intrathecal baclofen (ITB) therapy in spacticity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A26%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20intrathecal%20baclofen%20(ITB)%20therapy%20in%20spacticity&rft.jtitle=Turkish%20neurosurgery&rft.au=Ucar,%20Tanju&rft.date=2011-01&rft.volume=21&rft.issue=1&rft.spage=59&rft.epage=65&rft.pages=59-65&rft.issn=1019-5149&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E849431239%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=849431239&rft_id=info:pmid/21294093&rfr_iscdi=true